MedTrace Logo

Safety and Efficacy Study of an Edible Colonoscopy Preparation

NCT03332485 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-03-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of ECP (PEG 3350) Colon Prep Kit compared with MoviPrep split-dose as a colon-cleansing preparation for colonoscopy.

Conditions

  • Colon Prep for Colonoscopy

Interventions

DRUG

ECP Colon Prep Kit

ECP Colon Prep Kit

DRUG

MoviPrep®

MoviPrep®

Sponsors & Collaborators

  • Sebela Pharmaceuticals Development LLC

    lead INDUSTRY

Principal Investigators

  • Sue Hall · Sebela Pharmaceuticals Development LLC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-20
Primary Completion
2018-03-14
Completion
2018-03-14
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03332485 on ClinicalTrials.gov